Company News
-
Deebio’s Global Bio-enzyme Journey: 27 Years, 30 Countries and Regions
DEYANG, China, Aug. 31, 2021 /PRNewswire/ -- Sichuan Deebiotech Co., Ltd. (hereinafter referred to as Deebio) recently celebrated its 20th anniversary of continuous exports to the EU during the 86th API China. The company's European partners sent congratulatory video, wh...Read more -
Hidden Champion Deebio’s 26th Anniversary of Bio-enzyme Export to Japan
CHENGDU, CHINA / ACCESSWIRE / August 20, 2021 / “Deebio’s 26th Anniversary Celebration of Export to Japan” was successfully held in Chengdu, China, on March 29. Professor Yu Rong, Director of the Department of Biotechnology and Pharmacology of the West China School of Pharmacy, Sichuan Universit...Read more -
To Be the Leader of China’s Bio-enzyme API Industry
GUANGHAN, CHINA / ACCESSWIRE / August 20, 2021 / On April 27, Zhang Ge, Board Chairman and President of Sichuan Deebio Pharmaceutical Co., Ltd. (hereinafter referred to as Deebio), participated in the China Bio-enzyme High-quality Development Seminar. He said at the meet...Read more -
Deebio Launches New Products Helping Stabilize Global Supply of Thyroid API
NEW YORK, NY / ACCESSWIRE / July 7, 2021 / Recently, another piece of good news comes from the Chinese bio-enzyme API industry. The first batch of thyroid API produced by Sichuan Deebio Pharmaceutical Co., Ltd. has been sent to the United States. It is reported that the ...Read more -
Deebio reached a strategic cooperation with MEDISCA on Thyroid API
Recently, Deebio reached a strategic cooperation with MEDISCA, a global pharmaceutical compounding company. Deebio will Exclusively supply thyroid API to Medisca in compliance with FDA regulations. Through this cooperation, The unstable and inconsistent supply will be po...Read more
